Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The Other Vaccines market in Chad has been steadily developing in recent years, driven by various factors such as customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.
Customer preferences: Chadian customers have shown a growing interest in vaccines beyond the traditional ones, such as those for polio and measles. This has led to an increased demand for other vaccines, including those for pneumococcal disease, meningococcal disease, and human papillomavirus (HPV). As the awareness of the importance of vaccination grows, more customers are willing to pay for these vaccines to protect themselves and their families.
Trends in the market: One of the key trends in the Other Vaccines market in Chad is the increasing availability of these vaccines. Previously, many of these vaccines were not widely available in the country, but this has been changing in recent years. Pharmaceutical companies have been expanding their distribution networks in Chad, making these vaccines more accessible to customers. Additionally, as more healthcare providers become trained in administering these vaccines, the market is expected to continue to grow.
Local special circumstances: Chad faces a number of unique challenges when it comes to healthcare, including a lack of infrastructure and resources. However, the government has made a commitment to improving healthcare in the country, and this has included investing in vaccination programs. As a result, there has been an increase in the number of vaccination campaigns in Chad, which has helped to raise awareness of the importance of vaccination and increase demand for these products.
Underlying macroeconomic factors: Chad is one of the poorest countries in the world, with a low GDP per capita and high levels of poverty. However, the country has been experiencing some economic growth in recent years, which has helped to increase demand for healthcare products, including vaccines. Additionally, Chad has a young population, which is more likely to require vaccines than older populations. As the population continues to grow, the demand for vaccines is likely to increase as well.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
